NEWARK, Del., September 13, 2022 — The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) along with the University of Delaware are pleased to announce $3M in Congressionally-directed funding from the National Institute of Standards and Technology (NIST) for new equipment which will support the advancement of biopharmaceutical manufacturing processes and provide expanded opportunities for workforce development.
“We are grateful for the continued financial support from NIST that will help establish additional testbeds for biomanufacturing innovation and provide critical infrastructure to advance workforce training,” shares Kelvin H. Lee, NIIMBL institute director.
NIST Director Dr. Laurie E. Locascio, Senator Chris Coons, and Senator Tom Carper, came together with leaders from academia and industry to hold a press conference at NIIMBL headquarters on Tuesday, September 22, announcing the award along with their commitment to support the state’s bioeconomy ecosystem and further innovations in biopharmaceutical manufacturing to benefit the world.
“For each dollar of federal funds from NIST, the private sector has contributed more than three dollars to NIIMBL, which is a strong indication that NIIMBL works and delivers returns,” Dr. Locascio said. “The work NIIMBL leads helps make sure that breakthrough inventions don’t get stuck in labs or made overseas but get manufactured here in the United States.”
NIIMBL, with headquarters at the University of Delaware STAR Campus, is comprised of over 200 members and for over six years uniquely brings together industry, academia, non-profits and federal stakeholders to collaborate and advance the biopharmaceutical manufacturing industry.
Learn more at NIIMBL.org.
About NIIMBL
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is a public-private partnership whose mission is to accelerate biopharmaceutical innovation, support the development of standards that enable more efficient and rapid manufacturing capabilities, and educate and train a world-leading biopharmaceutical manufacturing workforce, fundamentally advancing U.S. competitiveness in this industry. NIIMBL is part of Manufacturing USA®, a diverse network of federally sponsored manufacturing innovation institutes, and is funded through a cooperative agreement with the National Institute of Standards and Technology (NIST) in the U.S. Department of Commerce with significant additional support from its members.
Contact:
News Media
Maria X. Chacon
Director of Marketing and Communications
302-831-2337